Funding routes for pharmaceuticals.

Context: The pharmaceutical company had a high cost orphan drug on the market, with a second one about to be launched, and was looking for a map of potential funding pathways for these drugs.
Actions: A comprehensive review of all public and private funding options for pharmaceuticals was conducted, including analysis of all state and federal budgets and programs that could potentially be sources of funding. These funding routes were mapped into a decision tree and a range of funding strategies proposed.
Outcome: A more informed company that is able to identify potential funding sources to assist its customers and patients.

Disclaimer | Copyright Statement